For Immediate Release
Chicago, IL – February 7, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Exxon Mobil (XOM - Free Report) , Chevron (CVX - Free Report) , International Business Machines (IBM - Free Report) , Gilead Sciences (GILD - Free Report) and Edwards Lifesciences (EW - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Coronavirus Starting to Weigh on 2020 Q1 Earnings Estimates
The Zacks Research Daily presents the best research output of our analyst team. In addition to giving you a real-time update on the ongoing 2019 Q4 earnings season and evolving impact of the virus outbreak on estimates for the current period, we present here new research reports on 16 major stocks, including Exxon Mobil, Chevron and International Business Machines. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Q4 Earnings Season Scorecard (as of February 6th, 2020)
Including all of this morning's reports, we now have Q4 earnings reports from 305 S&P 500 members or 61% of the index's total membership. Total earnings for these 305 index members are up +0.5% from the same period last year on +4.1% higher revenues, with 71.8% beating EPS estimates and 67.5% beating revenue estimates.
This is better performance than we have seen from this same group of companies in the recent past, even though earnings growth remains anemic and a lower proportion of companies are beating EPS estimates.
Looking at Q4 as a whole, combining the actual results that have come out with estimates for the still-to-come reports, total earnings are now expected to be up +0.5% on +4.2% higher revenues.
2020 Q1 Estimates Coming Down
Estimates for the current period (2020 Q1) have started coming down in a notable way over the last few days, with the Coronavirus impact a big driver for the estimate cuts. S&P 500 earnings in 2020 Q1 are now expected to be up +1.7%, sharply down from +3.4% last week.
Given the evolving nature of this headwind, it is reasonable to expect that 2020 Q1 estimates will come down further in the coming days.
For a complete look at the Q4 earnings season and expectations for the current and coming quarters, please check out our weekly Earnings Trends report here >>> Q4 Earnings Season Scorecard
Exxon Mobil shares have lagged the peer group lately, but the Zacks analyst likes the company for its bellwether status in the energy space and optimal integrated capital structure that has helped it come up with industry-leading returns.
The company owns some of the most prolific upstream assets globally, with a number of major projects slated to come online over the next few years. Notably, ExxonMobil has made 16 oil discoveries in offshore Guyana and estimates 750,000 barrels of oil production per day from the region by 2025.
However, the company’s downstream and chemical businesses significantly underperformed in 2019, resulting in lower-than-expected earnings. The units are unlikely to recover in the coming quarters owing to scheduled maintenance activities. As such, the stock warrants a cautious stance.
(You can read the full research report on Exxon Mobil here >>>)
Like all energy stocks, Chevron shares have struggled lately, but they have nevertheless done better than the peer group as whole. Driving this outperformance is Chevron's status as one of the best-placed global integrated oil companies to achieve sustainable production ramp-up.
America’s No. 2 energy company’s existing project pipeline is among the best in the industry, thanks to planned expansion in the lucrative Permian Basin. Chevron’s substantial Permian holdings of 2.2 million net acres realized production growth of 154 MBOE/d in 2019 with Chevron targeting output of 900,000 barrels per day in 2023.
Chevron’s well economics in the play also continues to improve as it has been able to achieve a 40% reduction in its expenses since 2015.
(You can read the full research report on Chevron here >>>)
IBM’s shares have gained +13.5% over the past three months against the S&P 500's rise of +8.1%. The Zacks analyst believes that IBM’s improving position in the hosted cloud, security and analytics aided revenue performance.
Moreover, RedHat acquisition has helped IBM to enhance containerized software capabilities. Robust adoption of security solutions, including Resilient and QRadar, bodes well. Growing clout of Watson Health and growth in Payer, Provider, Imaging and Life Sciences domains are noteworthy.
Further, gains from z15 and high demand for data privacy and resiliency solutions across hybrid cloud are positives. However, stiff competition in the cloud computing market and high debt level pose concerns. Also, IBM’s time-consuming business model transition to cloud is a headwind.
(You can read the full research report on IBM here >>>)
Other noteworthy reports we are featuring today include Gilead Sciences and Edwards Lifesciences.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.